Optimi Health is trading at $4.19, up 5.01% after hours, with no specific catalyst established by available evidence.

  • No company announcement dated October 9 was found; an October 8 update welcomed expanded access under Australia’s psychedelic-therapy framework, but sources do not link it to the move.
  • The S&P 500, Nasdaq Composite, and Dow Jones each rose more than 0.5% on October 9, providing a positive backdrop but not confirming the reason.
  • No trading-volume information was provided.